Abstract: Approaches to enable the configuration of computing resources for executing virtual machines on behalf of users to be cryptographically attested to or verified. When a user requests a virtual machine to be provisioned, an operator of the virtualized computing environment can initiate a two phase launch of the virtual machine. In the first phase, the operator provisions the virtual machine on a host computing device and obtains cryptographic measurements of the software and/or hardware resources on the host computing device. The operator may then provide those cryptographic measurements to the user that requested the virtual machine. If the user approves the cryptographic measurements, the operator may proceed with the second phase and actually launch the virtual machine on the host. In some cases, operator may compare the cryptographic measurements to a list of approved measurements to determine whether the host computing device is acceptable for hosting the virtual machine.

Abstract: Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa.

Abstract: Apparatuses, systems, and methods for user equipment (UE) devices to perform a postponement of a data service request are described. A UE may detect a data service request failure during cell reselection and postpone a resend of the data service request based on a status of the cell reselection. The status may be an indication that the UE is attempting to camp on a cell or that the UE is monitoring one or more metrics associated with cell reselection. To postpone the data service request, the UE may postpone the data service request for a specified period of time or until the cell reselection is complete. The status may be monitored on a first layer of a protocol stack and the data service request may generated by a second layer of the protocol stack. The postponement may be for a fixed or variable time period.

Abstract: Embodiments relate to an emergency wireless link in a data center comprising a plurality of servers. An aspect includes an emergency wireless link system in a data center comprising a plurality of servers. The emergency wireless link system includes an input interface to receive an input from a sensor coupled to one of the plurality of servers or to an auxiliary system among a plurality of auxiliary systems. The plurality of auxiliary systems includes a power supply system. The system also includes a processor to compare the input with a plurality of conditions, declare an emergency based on the input matching one of the plurality of conditions, and output one or more messages corresponding with the one of the plurality of conditions based on declaring the emergency. The system further includes a transmitter to wirelessly transmit the one or more messages output by the processor.

Abstract: An apparatus comprises a storage controller coupled to at least one multi-region storage device. The at least one multi-region storage device comprises two or more storage regions, the two or more storage regions comprising a first storage region associated with a first set of failure characteristics and at least a second storage region associated with a second set of failure characteristics different than the first set of failure characteristics. The storage controller is configured to replicate in the second storage region at least a portion of data that is stored in the first storage region.

Abstract: The present invention provides bicyclic heterocyclyl kinase enzyme inhibitor compounds of formula (I), which are therapeutically useful as kinase inhibitors, particularly IRAK4 inhibitors. wherein A, Y, Z, X1, X2, X3, R1, R3, ‘m’, ‘n’ and ‘p’ have the meanings given in the specification and pharmaceutically acceptable salt or stereoisomer thereof that are useful in the treatment and prevention of diseases or disorder, in particular their use in diseases or disorder mediated by kinase enzyme, particularly IRAK4 enzyme. The present invention also provides pharmaceutical composition comprising at least one of the compounds of compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

Abstract: Described herein are compositions and methods using same for forming a silicon-containing film such as, without limitation, a carbon doped silicon oxide film, a carbon doped silicon nitride, a carbon doped silicon oxynitride film in a deposition process. In one aspect, the composition comprises at least cyclic carbosilane having at least one Si—C—Si linkage and at least one anchoring group selected from a halide atom, an amino group, and combinations thereof.

Abstract: A bag to be used for travelling, designed for convenience. It holds a traveller's items, including a mobile phone and camera. It helps store the traveller's items safely, conveniently and also helps charge them. It is made of strong material to provide slash resistance, durability and ease of mind during travel.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an ether (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.

Abstract: In one embodiment, a flexible strain sensor includes a flexible polymeric substrate having a top surface and a layer of amorphous carbon formed on the top surface of the substrate.

Abstract: Regulator circuitry may include a plurality of output circuits to generate a plurality of regulated output voltages. The regulator circuitry may include a single operational amplifier and a single feedback loop for regulation, which may reduce space and power consumed by the regulator circuitry. A transconductor and current mirror circuitry may be included to generate the plurality of regulated output voltages based a single operational amplifier output voltage generated with the single operational amplifier and feedback loop.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.

Abstract: An insert for a backpack or travel bag is used for travelling with electronic devices and charging them on the go. It is designed for convenience. It holds a traveller's items, including a mobile phone and camera. It helps store the traveller's items safely, conveniently and also helps charge them. It is made of strong material to provide slash resistance, durability and ease of mind during travel.

Abstract: An insert for a travel bag is used for travelling with electronic devices and charging them on the go. It is designed for convenience. It holds a traveller's items, including a mobile phone and camera. It helps store the traveller's items safely, conveniently and also helps charge them. It is made of strong material to provide slash resistance, durability and ease of mind during travel.

Abstract: The present invention provides methods for treating a cancer in a subject and for inhibiting tumor growth, metastasis or a dihydrorotate oxygenase enzyme activity of a tumor or cancer cell. At least one trisubstituted benzotriazole derivative with the formula (I) is administered to the subject or is contacted with the cancer cell. Compounds of formula (I) have substituents R1, R2 and R3 which have the meanings given in the specification, and pharmaceutically acceptable salts thereof.

Abstract: An apparatus for storing and retrieving electronic components such as, but not limited to: capacitors; resistors; and integrated circuits. Components are stored based on single package single location in lockable racks in a transportable cart. Information for each stored component, such as its part number, location, and quantity is stored in the local electronic board and is shared via Wi-Fi to a network of PCs.

Abstract: A system and method for performing self-learning for adaptively achieving passenger comfort enhancement in an autonomous vehicle. The system comprises a plurality of sensor inputs. Each sensor input provides data representative of voice responses and image responses from a passenger in the vehicle. A controller is coupled to the plurality of sensor inputs. The controller generates and updates a reward function that includes a plurality of driving state transitions. The reward function is updated based on destination information and the data representative of the voice and image responses. The controller further generates a goal function that determines an optimized driving state transition updates the goal function based on the updated reward function and a previous goal function. The controller also generates a vehicle speed control signal, based on the updated goal function, to control the speed of the autonomous vehicle.

Abstract: A phase-locked loop (PLL) circuit may be configured to generate a plurality of oscillating signals based on a single control voltage generated based on a phase difference between an input signal and a feedback signal. One of the plurality of oscillating signals may be used to generate the feedback signal.

Abstract: A first application executing on a client device can access content and present the content to a user. An operating system of the client device can store into a database metadata identifying at least the content. A second application executing on the client device can access the content. In response, the operating system can determine that the first application already presented the content by accessing the metadata in the database. Responsive to the operating system determining that the first application already presented the content, the operating system can indicate to the second application not to present the content.

Abstract: A controller may receive interface information, associated with one or more interfaces used to communicate with one or more components of a vehicle, and may receive application information associated with one or more applications configured to receive information from the one or more components via the one or more interfaces. The controller may store, based on the interface information and the application information, registration information that indicates whether the one or more applications are permitted to communicate via the one or more interfaces. The controller may receive, from an application of the one or more applications, a request for vehicle information from an interface of the one or more interfaces. The controller may verify whether the application is permitted to communicate via the interface, and may selectively route the request for the vehicle information to the interface based on verifying whether the application is permitted to communicate via the interface.